menu
    • menu

    Company profile for ImmunOs Therapeutics

    NEW Drugs in Dev.: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ImmunOs Therapeutics AG, a spin-off of the University of Zurich and University of Basel, is leading the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment that not only have direct anti-tumor effects but also remodel the tumor microenvironment and enhance the efficacy of existing immunotherapies. The team has extensive expertise in the field of drug development and g...
    ImmunOs Therapeutics AG, a spin-off of the University of Zurich and University of Basel, is leading the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment that not only have direct anti-tumor effects but also remodel the tumor microenvironment and enhance the efficacy of existing immunotherapies. The team has extensive expertise in the field of drug development and global commercialization in immunotherapy, immunology, and oncology. Our mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease​.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunOs TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    WAGISTRASSE 14 8952 SCHLIEREN
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunostherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunos-therapeutics-ag
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunos Therapeutics Shows IOS-1002 Promise In Advanced Solid
    Immunos Therapeutics Shows IOS-1002 Promise In Advanced Solid

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/immunos-therapeutics-reports-promising-clinical-activity-of-ios-1002-in-advanced-solid-tumors

    PHARMIWEB
    20 Oct 2025
    Share Share
    ProBioGen, ImmunOs Therapeutics Extend Clinical Mfg. Pact
    ProBioGen, ImmunOs Therapeutics Extend Clinical Mfg. Pact

    13 Apr 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-04-13/probiogen-immunos-therapeutics-extend-clinical-mfg-pact/?widget=listSection

    CONTRACT PHARMA
    13 Apr 2023
    Share Share
    ProBioGen & ImmunOs join hands to deliver innovative therapy for cancer patients
    ProBioGen & ImmunOs join hands to deliver innovative therapy for cancer patients

    13 Apr 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/probiogen-and-immunos-therapeutics-join-hands-to-deliver-innovative-therapy-for-cancer-patients-13992

    INDIAN PHARMA POST
    13 Apr 2023
    Share Share
    ImmunOs Therapeutics gets TGA approval to begin first-in-human trial of IOS-1002
    ImmunOs Therapeutics gets TGA approval to begin first-in-human trial of IOS-1002

    19 Jan 2023

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=155816&sid=2

    PHARMABIZ
    19 Jan 2023
    Share Share
    ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD
    ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD

    05 Oct 2022

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2022-10-04/immunos-therapeutics-announces-appointment-of-joseph-leveque-md-to-its-board-of-directors

    PHARMIWEB
    05 Oct 2022
    Share Share
    A former Merck director's Pfizer-backed biotech in nascent LILRB field
    A former Merck director's Pfizer-backed biotech in nascent LILRB field

    07 Jun 2022

    // Kyle LaHucik ENDPTS

    https://endpts.com/a-former-merck-directors-pfizer-backed-biotech-will-take-on-his-old-bosses-in-nascent-lilrb-field/

    Kyle LaHucik ENDPTS
    07 Jun 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search